HealthyDirect · GrowthFit for a long SIP
Baroda BNP Paribas Mid Cap Fund
Baroda BNP Paribas Mutual FundEquity Scheme - Mid Cap Fund4.6 years
The Scheme seeks to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the mid capitalization segment. The fund will emphasize on companies that appear to offer opportunities for long-term growth and will be inclined towards companies that are driven by dynamic style of management and entrepreneurial flair.
- NAV
- 124.9134
- 30 Oct 2026
- 1Y
- +0.8%
- Trailing CAGR
- Upside capture
- +86%
- Vs NIFTY MIDCAP 150 TRI
- Downside capture
- +78%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 97% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
4.6 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.6%. Ask whether you can hold through a similar fall.
Vs category
Pass
97% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Ankeet Pandya · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 21.6% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 19%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+0.8%
- 3Y+15.3%
- 5Yn/a
- 10Yn/a
- SI+15.8%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-3.6%
- 3Y+5.9%
- 5Yn/a
- 10Yn/a
- Since inception
- +15.8%
- Calendar-day CAGR
- Excess 1Y
- +3.5%
- Category median, same plan and option
- 3Y win rate
- +97%
- Windows beating the median
- 3Y percentile
- 65
- Vs comparable share classes
- SIP 3Y XIRR
- +5.9%
- Simulated monthly SIP
- Worst rolling 3Y
- +14.1%
- 402 daily-ending windows
- Median rolling 3Y
- +21.3%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Official benchmark
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- +5.2%
- Fund minus TRI
- 3Y excess
- +1.5%
- Fund minus TRI
- Upside capture
- +86%
- Benchmark-up months
- Downside capture
- +78%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -18.6%
- Worst peak-to-trough
- Current
- -9.3%
- Below last peak
- Current spell
- 65 days
- Days below latest peak
- Time below peak
- +84%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 12 days
- 67 recovered episodes
- Longest recovery
- 262 days
- Trough to prior peak
1 Oct 2024 – 17 Nov 2025
Trough 28 Feb 2025 · recovered in 262 days
-18.6%
11 Apr 2022 – 2 Sept 2022
Trough 20 Jun 2022 · recovered in 74 days
-16.0%
26 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.0%
11 Feb 2026 – 21 Apr 2026
Trough 23 Mar 2026 · recovered in 29 days
-11.4%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
65
Vs category
72
Consistency
80
Risk-adjusted
60
Drawdown
53
Mean
66
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 97% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 78 holdings · top 10 are 21.6%.
- Top 5
- 12.0%
- Top 10
- 21.6%
- Largest holding
- 3.3%
- Effective holdings
- 68.0
Bharat Heavy Electricals Ltd
Industrials
3.3%
Indian Bank
Financial
2.3%
Ipca Laboratories Ltd
Healthcare
2.2%
Ami Organics Ltd
Healthcare
2.1%
GE T&D India Ltd
Industrials
2.1%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Edelweiss Mid Cap Fund
Edelweiss Mutual Fund
- 1Y
- -2.0%
- 3Y
- +19.0%
- Vol
- 17.1%
- Max DD
- -39.2%
- Sharpe
- 0.78
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
ITI Mid Cap Fund
ITI Mutual Fund
- 1Y
- -1.3%
- 3Y
- +17.7%
- Vol
- 16.4%
- Max DD
- -22.7%
- Sharpe
- 0.67
- 3Y win
- +100%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
HDFC Mid Cap Fund
HDFC Mutual Fund
- 1Y
- -3.0%
- 3Y
- +15.6%
- Vol
- 15.6%
- Max DD
- -39.5%
- Sharpe
- 0.86
- 3Y win
- +76%
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Axis Midcap Fund
Axis Mutual Fund
- 1Y
- +1.3%
- 3Y
- +16.1%
- Vol
- 14.9%
- Max DD
- -29.4%
- Sharpe
- 0.82
- 3Y win
- +41%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
Sundaram Mid Cap Fund
Sundaram Mutual Fund
- 1Y
- -4.6%
- 3Y
- +16.4%
- Vol
- 16.5%
- Max DD
- -44.3%
- Sharpe
- 0.70
- 3Y win
- +56%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER